Notable Runner: Innocoll Holdings PLC Can’t Be More Risky. Just Reaches Yearly Low

Notable Runner: Innocoll Holdings PLC Can't Be More Risky. Just Reaches Yearly Low

The stock of Innocoll Holdings PLC (NASDAQ:INNL) hit a new 52-week low and has $3.15 target or 13.00% below today’s $3.62 share price. The 6 months bearish chart indicates high risk for the $108.95M company. The 1-year low was reported on Nov, 3 by If the $3.15 price target is reached, the company will be worth $14.16M less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 62,994 shares traded hands. Innocoll Holdings PLC (NASDAQ:INNL) has declined 51.25% since April 1, 2016 and is downtrending. It has underperformed by 52.46% the S&P500.

Innocoll Holdings PLC (NASDAQ:INNL) Ratings Coverage

Out of 2 analysts covering Innocoll AG (NASDAQ:INNL), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Innocoll AG has been the topic of 2 analyst reports since April 28, 2016 according to StockzIntelligence Inc. Janney Capital initiated the shares of INNL in a report on Thursday, April 28 with “Buy” rating. As per Thursday, June 30, the company rating was initiated by FBR Capital.

According to Zacks Investment Research, “Innocoll Holdings develops and manufactures pharmaceutical products and medical devices through its proprietary collagen-based technologies. The company’s product include CollaGUARD(Ex-US), CollatampG(R), Septocoll(R), RegenePro(R), Collieva(R), CollaCare(R), Collexa(R) and Zorpreva(TM). It operates primarily in Asia, Australia, Canada, Europe, Latin America, the Middle East and the United States. Innocoll AG, formerly known as Innocoll GmbH, is headquartered in Athlone, Ireland.”

More notable recent Innocoll Holdings PLC (NASDAQ:INNL) news were published by: which released: “Innocoll Holdings plc Announces Closing of Public Offering” on June 22, 2016, also with their article: “Innocoll Holdings plc Announces Second Quarter 2016 Financial and Operating …” published on August 17, 2016, published: “Innocoll Holdings plc Appoints Lesley Russell, MBChB, MRCP, as Chief Medical …” on April 20, 2016. More interesting news about Innocoll Holdings PLC (NASDAQ:INNL) were released by: and their article: “Innocoll Holdings plc Announces the Completion of Enrollment in Two Pivotal …” published on June 23, 2016 as well as‘s news article titled: “Innocoll started at outperform with $18 stock price target at FBR & Co.” with publication date: July 25, 2014.

INNL Company Profile

Innocoll Holdings Public Limited Company, incorporated on May 28, 2014, is a commercial-stage specialty pharmaceutical and medical device firm with late-stage development programs. The Firm operates through the segment of manufacture and sale of collagen pharmaceutical products. The Firm utilizes its collagen technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically. Using its processes at its manufacturing facility, the Company derives and purifies bovine and equine collagen and then utilizes its technology platform to incorporate the purified collagen into its topical and implantable products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment